Mount Sinai Morningside

ADI Announces U.S. FDA 510(k) Clearance and the Commercial Launch of Sensinel by Analog Devices™ Cardiopulmonary Management (CPM) System

Retrieved on: 
Tuesday, March 5, 2024
Cloud, Analog Devices, Heart, ADI, Senior, CPM, Algorithm, Digital health, FDA, Food, Vital signs, Medicine, Cardiology, Hospital, Mount Sinai Morningside, Heart failure, Health, History, Food and Drug Administration, Patient, Conditional sentence

WILMINGTON, Mass., March 5, 2024 /PRNewswire/ -- Analog Devices, Inc. (Nasdaq: ADI) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and the commercial launch of the Sensinel™ Cardiopulmonary Management (CPM) System. The compact wearable device is a non-invasive, remote management system that captures cardiopulmonary measurements for chronic disease management such as heart failure. It is the first FDA clearance the company has received in its 59-year history.

Key Points: 
  • WILMINGTON, Mass., March 5, 2024 /PRNewswire/ -- Analog Devices, Inc. (Nasdaq: ADI ) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and the commercial launch of the Sensinel™ Cardiopulmonary Management (CPM) System.
  • The compact wearable device is a non-invasive, remote management system that captures cardiopulmonary measurements for chronic disease management such as heart failure.
  • "Since our founding, ADI has focused on accelerating breakthroughs that enrich lives through innovative products," said Patrick O'Doherty, Senior Vice President of Digital Healthcare at ADI.
  • The Sensinel CPM System is the next-generation solution for management of cardiopulmonary diseases like heart failure.

Teal Health Partners with Leading Health Organizations in a Nationwide Clinical Trial for their Self-Collect Device for Cervical Cancer Screening, the Teal Wand™

Retrieved on: 
Tuesday, January 9, 2024
Cervical cancer, Woman, Privacy, Research, Associate, Collection, Mount Sinai Morningside, SAN, University of Colorado, University of Wisconsin–Madison, University, Johns Hopkins, Yale University, Teal, Disease, Hospital, Health literacy, FDA, Doctor of Philosophy, Head, OBGYN, HPV, Clinical trial, Education, Trial of the century, American Cancer Society, Birth control

SAN FRANCISCO, Jan. 9, 2024 /PRNewswire/ -- Today, in honor of Cervical Cancer Awareness Month, Teal Health, a women's health company focused on increasing access to cervical cancer screenings in the US, announces the SELF-CERV clinical study, in progress at leading health organizations including Johns Hopkins, Yale University, University of Colorado, University of Wisconsin, Washington University, and many more. Teal Health's clinical trial is designed to support FDA submission and approval of their novel at-home self-collect device, the Teal Wand™. By offering an alternative to an in-person doctor's visit for a speculum exam, Teal Health will be able to provide women and people with a cervix a choice and greater access to this critical health screening, on which 1 in 4 women in the US are not up-to-date.

Key Points: 
  • Teal Health's clinical trial is designed to support FDA submission and approval of their novel at-home self-collect device, the Teal Wand™.
  • More than 50% of these diagnoses are later stage and among people who did not have a recent screening.
  • HPV testing is recommended as the preferred cervical cancer screening method by multiple medical guidelines, including the American Cancer Society.
  • This Cervical Cancer Awareness Month, Teal Health is raising awareness about the importance of life-saving cervical cancer screening with their 'Close the Screening Gap' initiative.

Fat Burning During Exercise Varies Widely Between Individuals; Study reveals limitations of commercial exercise machines

Retrieved on: 
Friday, August 11, 2023
Exercise, CDN, Obesity, University, Metabolism, Intelligence, Mount Sinai Hospital (Manhattan), Department of Medicine – University of Pamplona, Cardiovascular disease, Mount Sinai, Doctor of Philosophy, Division, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, Tel Aviv Sourasky Medical Center, Heart rate, Weight, MPH, Medical imaging, Dietary supplement, Nutrition, RD, MD, Mount Sinai Morningside, Medicine

NEW YORK, Aug. 11, 2023 /PRNewswire-PRWeb/ -- The best heart rate for burning fat differs for each individual and often does not align with the "fat burning zone" on commercial exercise machines, Icahn School of Medicine at Mount Sinai researchers report.

Key Points: 
  • The best heart rate for burning fat differs for each individual and often does not align with the "fat burning zone" on commercial exercise machines, Icahn School of Medicine at Mount Sinai researchers report.
  • NEW YORK, Aug. 11, 2023 /PRNewswire-PRWeb/ -- The best heart rate for burning fat differs for each individual and often does not align with the "fat burning zone" on commercial exercise machines, Icahn School of Medicine at Mount Sinai researchers report.
  • "People with a goal of weight or fat loss may be interested in exercising at the intensity which allows for the maximal rate of fat burning.
  • "We hope that this work will inspire more individuals and trainers to utilize clinical exercise testing to prescribe personalized exercise routines tailored to fat loss.

Nursing Teams and Staff at Mount Sinai Morningside Receive Awards for Excellence in Critical Care

Retrieved on: 
Tuesday, July 11, 2023
Senior, Surgery, Cardiac catheterization, AoC Beacon Awards, Engineer Research and Development Center, Health system, Unit, Emergency department, BSN, DNP, Hospital, Neurosurgery, Patient, Post-anesthesia care unit, Nursing, RN, Bariatric surgery, Health, Trauma, Morale, MHA, FAAN, Caregiver, Excellence, Mount Sinai Morningside, Mount Sinai Health System

NEW YORK, July 11, 2023 /PRNewswire-PRWeb/ -- The Mount Sinai Morningside nursing teams and staff of the Cardiac Catheterization Lab have received the Gold-level Beacon Award for Excellence from the American Association of Critical-Care Nurses, becoming the first and only Gold-level unit across the entire Mount Sinai Health System. Additionally, Mount Sinai Morningside Unit 8E has received the Silver-level Beacon Award for Excellence.

Key Points: 
  • NEW YORK, July 11, 2023 /PRNewswire-PRWeb/ -- The Mount Sinai Morningside nursing teams and staff of the Cardiac Catheterization Lab have received the Gold-level Beacon Award for Excellence from the American Association of Critical-Care Nurses, becoming the first and only Gold-level unit across the entire Mount Sinai Health System.
  • Additionally, Mount Sinai Morningside Unit 8E has received the Silver-level Beacon Award for Excellence.
  • "I am so proud of everyone who is a part of the Mount Sinai Morningside Cath Lab team for earning this Gold-level Beacon Award," said Ms. Joseph.
  • The Silver-level Beacon Award for Excellence was awarded to the Mount Sinai Morningside nursing unit 8E, led by Susan Ignacio, RN.

Talkiatry Co-Founder Dr. Georgia Gaveras Recognized as a 2023 Crain's Notable Health Care Leader

Retrieved on: 
Tuesday, May 16, 2023
Depression, Osteopathic medicine in the United States, Anxiety, Physician, Mount Sinai Morningside, ADHD, Research, Addiction medicine, Roosevelt Hospital (Edison, New Jersey), Columbia University Vagelos College of Physicians and Surgeons, Patient, Child, Medical Center, Touro College of Osteopathic Medicine, Adolescence, Growth, Entrepreneurship, Columbia University College of Dental Medicine, Kings County Hospital Center, Psychiatry, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Bipolar disorder, Nursing, Central New York Business Journal, Surgeon

The Notable Health Care Leader Award recognizes professionals in the New York and northern New Jersey metropolitan areas who devote their lives to building a healthier future.

Key Points: 
  • The Notable Health Care Leader Award recognizes professionals in the New York and northern New Jersey metropolitan areas who devote their lives to building a healthier future.
  • As the leader of Talkiatry's clinical team, Dr. Gaveras focuses on providing quality care and improving patient outcomes at scale.
  • "I am honored to be named one of Crain's Notable Health Care Leaders," said Dr. Gaveras.
  • To view the complete list of Notable Health Care Leaders, please visit here .

Median Technologies Announces Formation of Clinical Advisory Board for iBiopsy® Lung Cancer Screening

Retrieved on: 
Monday, October 3, 2022
Biotechnology, Medical Devices, Other Health, Health, Oncology, LCS, Liver cancer, University of Pennsylvania Health System, Hospital, Journal of Thoracic Oncology, Precision medicine, Knowledge, Data science, HCC, Icahn School of Medicine at Mount Sinai, Radiology, Technology, SME, Division, Intervention, Mount Auburn Hospital, Associate professor, Cave rescue, NASH, View, Lung cancer, Software, University of Insubria, Hospital of the University of Pennsylvania, CCO, Cancer, Patient, Lung cancer screening, Diagnosis, University, Faculty, Clinical research, CAB, Prognosis, Physician, Critical care, Lists of diseases, BPI, Cirrhosis, Associate, Department, COO, Section, DS, Solution, Oncology, Medical device, Harvard Medical School, Artificial intelligence, Medical imaging, Medicine, Mount Sinai Morningside

Median Technologies (Paris:ALMDT) announced today the formation of their Clinical Advisory Board (CAB) for iBiopsy Lung Cancer Screening.

Key Points: 
  • Median Technologies (Paris:ALMDT) announced today the formation of their Clinical Advisory Board (CAB) for iBiopsy Lung Cancer Screening.
  • I am pleased and honored to be working with this team of distinguished and highly accomplished clinicians, whos wealth of knowledge and experience will help Median deliver on optimizing the Lung Cancer Screening routine and saving patient lives.
  • iBiopsy currently focuses on lung cancer, liver cancer (HCC) and liver fibrosis (NASH).
  • About Median Technologies: Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone.

USOSM Making Moves in the American Midwest, Announces Third Partnership in the State of Indiana

Retrieved on: 
Wednesday, April 13, 2022
American Association of Oral and Maxillofacial Surgeons, News, CEO, Indiana University School of Medicine, Dentures, Marketing, Oral and maxillofacial surgery, Association, Memorial Hospital, American Dental Society of Anesthesiology, Indiana University School of Dentistry, Mount Sinai Morningside, Cleft lip and cleft palate, Patient, Apicoectomy, Growth, Health, Oral, ST, Anesthesiology, Breast implant, Dentist, American Association, Industry, Indiana University, Partnership, OMS, Dentistry, TMJ

IRVING, Texas, April 13, 2022 /PRNewswire-PRWeb/ -- U.S. Oral Surgery Management (USOSM) – a specialty management services company that exclusively serves premier oral and maxillofacial surgeons – has formed a new partnership with Michiana Oral & Maxillofacial Surgery of South Bend, IN. This is USOSM's third practice partner in the state.

Key Points: 
  • Oral Surgery Management (USOSM) has formed a new partnership with Michiana Oral & Maxillofacial Surgery of South Bend, IN.
  • Oral Surgery Management ( USOSM ) a specialty management services company that exclusively serves premier oral and maxillofacial surgeons has formed a new partnership with Michiana Oral & Maxillofacial Surgery of South Bend, IN.
  • This is an outstanding practice in a significant market and we're excited to announce our partnership," said Richard Hall, USOSM president and CEO.
  • Dr. Asdell is a board certified oral surgeon and a graduate of Indiana University and the Indiana University School of Dentistry.

Woman's Selects Rene Ragas as Next CEO

Retrieved on: 
Friday, March 18, 2022
Lake Pontchartrain, Raga, Multimedia, Board, Franciscan Missionaries of Our Lady University, Culture, The Business Council, Woman's Hospital of Texas, Tamanend, BATON, Hospital, Woman, Pregnancy, Queen of Angels Hospital, Cancer, Duke University Health System, CEO, MD, Industry, Biology, American College, Mount Sinai Morningside, Physician, Commerce, Tulane University, Patient, Volunteering, Management, Medicine, Southeastern Louisiana University

BATON ROUGE, La., March 18, 2022 /PRNewswire/ -- Woman's Hospital has chosen Rene Ragas, FACHE, as its next president and chief executive officer. Ragas is a Louisiana native with more than two decades of experience as a healthcare executive in the Baton Rouge area and surrounding regions. Most recently, he has served Franciscan Missionaries of Our Lady (FMOL) Health System as CEO of Our Lady of the Angels Hospital in Bogalusa since 2014 and Northshore Market President since 2017.

Key Points: 
  • BATON ROUGE, La., March 18, 2022 /PRNewswire/ --Woman's Hospital has chosen Rene Ragas, FACHE, as its next president and chief executive officer.
  • Ragas is a Louisiana native with more than two decades of experience as a healthcare executive in the Baton Rouge area and surrounding regions.
  • Ragas, who also has a deeply personal connection to Woman's, will assume the role of CEO in May.
  • Ragas will take the reins from Paul Cleckner, who has served as interim CEO since the fall when Dr. Barbara Griffith returned home to begin her tenure as CEO of Duke Raleigh Hospital.

The Mount Sinai Hospital's Department of Geriatrics Remains No. 1 in U.S. News & World Report Specialty Rankings for Second Year

Retrieved on: 
Tuesday, July 27, 2021
Continuum Health Partners, Hospitals, Manhattan, Health care, Mount Sinai Hospital, Mount Sinai West, Sinai-Grace Hospital, Mount Sinai Morningside, Mount Sinai Beth Israel, Mount Sinai South Nassau, Sinai Hospital, Sinai

In this year's report, The Mount Sinai Hospital saw improvements in six specialties, including significant leaps in Cancer, which rose to No.

Key Points: 
  • In this year's report, The Mount Sinai Hospital saw improvements in six specialties, including significant leaps in Cancer, which rose to No.
  • The Mount Sinai Hospital specialties ranked among the top 50 nationally this year were Geriatrics, ranked No.
  • Mount Sinai Beth Israel, Mount Sinai Morningside, Mount Sinai West, and Mount Sinai South Nassau were all ranked regionally.
  • 14 in the nation for National Institutes of Health funding, Newsweek's "The World's Best Smart Hospitals" ranks The Mount Sinai Hospital as No.